Charles River Laboratories International, Inc. (CRL) Stock Price, Quote & AI Analysis

Live CRL stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Charles River Laboratories International, Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Charles River Laboratories International, Inc. (CRL), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

CRL
Charles River Laboratories International, Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
162.540000
High
171.930000
Low
161.455000
Volume
941,365
VWAP
-
Market Cap
$8,083,148,957.04
52W Range
$91.86 - $228.88
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
May 5, 2026 Q1
Before Open
EPS Estimate: $2.5826
Revenue Estimate: $1,005,893,744.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Charles River Laboratories International, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Charles River Laboratories International, Inc. Overview

Company information

Company Overview

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Company Details
Market Cap
$8.35B
Shares Outstanding
49,215,500
Weighted Shares Outstanding
49,215,471
CEO
James C. Foster
Address
251 BALLARDVALE ST, WILMINGTON, MA, 01887
Employees
20,100
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
XNYS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Charles River Laboratories International, Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...